05:50 PM EDT, 09/09/2025 (MT Newswires) -- Lucid Diagnostics ( LUCD ) said late Tuesday it plans an underwritten public offering of its shares.
The company said it also plans to grant its underwriters a 30-day option to buy additional shares.
Proceeds will be used for working capital and general corporate purposes, Lucid said.
Shares were down over 11% during after-hours trading.